N Tang, WX Song, J Luo, RC Haydon… - Clinical orthopaedics and …, 2008 - Springer
Osteosarcoma is the most common nonhematologic malignancy of bone in children and adults. The peak incidence occurs in the second decade of life, with a smaller peak after age …
AC Mertens, Q Liu, JP Neglia… - Journal of the …, 2008 - academic.oup.com
Background The proportion of pediatric and adolescent cancer patients surviving 5 years has increased during the past four decades. This growing population of survivors remains at …
R Mody, S Li, DC Dover, S Sallan… - Blood, The Journal …, 2008 - ashpublications.org
Survivors of childhood acute lymphoblastic leukemia (ALL) are at risk for late effects of cancer therapy. Five-year ALL survivors (< 21 years at diagnosis; n= 5760 eligible, 4151 …
T Marees, AC Moll, SM Imhof… - JNCI: Journal of the …, 2008 - academic.oup.com
Background Survivors of hereditary retinoblastoma have an elevated risk of developing second malignancies, but data on the risk in middle-aged retinoblastoma survivors (ie, those …
G Lahat, A Lazar, D Lev - Surgical Clinics of North America, 2008 - Elsevier
Sarcomas are a heterogeneous group of tumors that may have many etiologies. The incidence of histologic subtypes differs significantly between children and adults. The …
Wilms tumour is the most common malignant renal tumour in children. Dramatic improvements in survival have occurred as the result of advances in anaesthetic and …
A Borgmann, C Zinn, R Hartmann, R Herold… - European journal of …, 2008 - Elsevier
PURPOSE: To investigate the cumulative incidence of and the risk factors for developing second malignant neoplasms (SMN) in children and adolescents following treatment for …
R Goldsby, C Burke, R Nagarajan, T Zhou, Z Chen… - Cancer, 2008 - Wiley Online Library
BACKGROUND. The growing number of individuals surviving childhood cancer has increased the awareness of adverse long‐term sequelae. One of the most worrisome …
F Navid, C Billups, T Liu, MJ Krasin… - European journal of …, 2008 - Elsevier
BACKGROUND: Patients are at risk of second malignancies (SM) after treatment for Ewing sarcoma family of tumours (ESFT). METHODS: We performed a retrospective review of 237 …